Q3 Earnings Estimate for Transcat Issued By Northland Capmk

Transcat, Inc. (NASDAQ:TRNS) – Northland Capmk issued their Q3 2025 EPS estimates for shares of Transcat in a report issued on Wednesday, October 30th. Northland Capmk analyst E. Jackson expects that the scientific and technical instruments company will post earnings of $0.41 per share for the quarter. The consensus estimate for Transcat’s current full-year earnings is $2.06 per share. Northland Capmk also issued estimates for Transcat’s Q4 2025 earnings at $0.63 EPS and FY2029 earnings at $3.45 EPS.

A number of other analysts have also recently commented on the company. HC Wainwright reissued a “buy” rating and issued a $156.00 price target on shares of Transcat in a research report on Tuesday. Northland Securities dropped their price target on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a research note on Wednesday. Oppenheimer reiterated an “outperform” rating and set a $130.00 target price (down from $155.00) on shares of Transcat in a research note on Wednesday. StockNews.com downgraded Transcat from a “hold” rating to a “sell” rating in a report on Tuesday. Finally, Craig Hallum lowered their target price on shares of Transcat from $138.00 to $113.00 and set a “buy” rating on the stock in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, Transcat currently has a consensus rating of “Hold” and a consensus target price of $127.25.

Transcat Stock Down 0.5 %

Shares of TRNS stock opened at $99.00 on Thursday. The business’s fifty day moving average is $122.86 and its 200 day moving average is $122.18. The stock has a market cap of $905.85 million, a price-to-earnings ratio of 58.58 and a beta of 0.67. Transcat has a twelve month low of $84.45 and a twelve month high of $147.12.

Transcat (NASDAQ:TRNS) last announced its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.12). The firm had revenue of $67.83 million during the quarter, compared to the consensus estimate of $70.30 million. Transcat had a return on equity of 8.48% and a net margin of 5.69%. The firm’s revenue was up 8.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.41 EPS.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. DekaBank Deutsche Girozentrale bought a new position in Transcat in the second quarter worth approximately $40,000. nVerses Capital LLC bought a new position in shares of Transcat during the 3rd quarter valued at approximately $60,000. First Horizon Advisors Inc. increased its holdings in Transcat by 26.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company’s stock worth $72,000 after acquiring an additional 125 shares in the last quarter. Fifth Third Bancorp raised its stake in Transcat by 95.8% during the 2nd quarter. Fifth Third Bancorp now owns 656 shares of the scientific and technical instruments company’s stock worth $79,000 after acquiring an additional 321 shares during the period. Finally, Quest Partners LLC bought a new stake in Transcat during the 2nd quarter worth approximately $109,000. 98.34% of the stock is owned by hedge funds and other institutional investors.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.